We are live on
!
Find out more
VCM
Vigilant Capital Management Portfolio holdings
AUM
$1.34B
1-Year Est. Return
15.33%
This Fund
S&P 500
This Quarter
Est. Return
+7.02%
1 Year Est. Return
+15.33%
3 Year Est. Return
+48.75%
5 Year Est. Return
+82.97%
10 Year Est. Return
+200.45%
AUM
$1.24B
AUM Growth
+$112M
(+10%)
Cap. Flow
+$32.7M
Cap. Flow
% of AUM
2.64%
Top 10 Holdings %
Top 10 Hldgs %
29.94%
Holding
452
New
96
Increased
129
Reduced
64
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baker Hughes
BKR
|
+$15.8M |
| 2 |
GrafTech
EAF
|
+$7.81M |
| 3 |
Abbott
ABT
|
+$2.22M |
| 4 |
Union Pacific
UNP
|
+$2.04M |
| 5 |
Nike
NKE
|
+$1.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$4.51M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$1M |
| 3 |
FRC
First Republic Bank
FRC
|
+$974K |
| 4 |
Sherwin-Williams
SHW
|
+$695K |
| 5 |
Linde
LIN
|
+$571K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.99% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 11.33% |
| 4 | Consumer Discretionary | 10.61% |
| 5 | Industrials | 10.61% |
Similar funds
JP
FCB
FCFS
BWM
LB
BWA
EWM
KC
Vigilant Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Vigilant Capital Management held 452 positions worth $1.24B, up 10% from $1.12B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Vigilant Capital Management's Q2 2021 filing shows 96 new, 129 increased, 64 reduced and 14 closed positions. Its largest new stake was Baker Hughes: 686,550 shares worth $15.7M. The largest sale was Alexion Pharmaceuticals, an estimated $4.51M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Vigilant Capital Management's largest Q2 2021 buy was Baker Hughes: 686,550 shares worth $15.7M.
- Vigilant Capital Management added most to Abbott in Q2 2021, an estimated $2.22M increase.
- Vigilant Capital Management's biggest Q2 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $4.51M.
- Vigilant Capital Management fully exited Schwab US Mid-Cap ETF in Q2 2021, selling an estimated $25K.
- Vigilant Capital Management's ten largest holdings make up 30% of its $1.24B portfolio in Q2 2021.
- Vigilant Capital Management opened 96 new positions and closed 14 in Q2 2021.
- Vigilant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.24B.
Based on Vigilant Capital Management's 13F filing for Q2 2021, filed 9 Jul 2021.